Strategy at CIRM: New Sources of Cash, More Funding Transparency, Better PR?
The California stem cell agency is huddling with industry, scientists and public as it wades through a revision of its strategic plan to determine how to spend its remaining $1.4 billion before the cash runs out.
CIRM officials have held at least 10 meetings with a variety of groups, including three public sessions. The next public hearing is Thursday in…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.